This website is using cookies. More details
BioMedomics COVID-19 IgM/IgG Rapid test

BioMedomics has developed and launched one of the world’s first rapid point-of-care lateral flow immunoassays for the diagnosis of coronavirus infection...

OXFORD BIOSYSTEMS and BIOMEDOMICS™ sign exclusive distribution agreement for UK

Founded in 2007, BioMedomics is a privately-held clinical diagnostics company in North Carolina, USA. Their researchers combine biology, biochemistry and...

Orion Diagnostica announce a change to their company name!

Orion Diagnostica are manufacturers of the UniQ product range, including the PIIINP RIA kit, and the microbiology products Hygicult, Uricult, Easicult...

 Products Clinical-Solutions Haematology


HaematologyOxford Biosystems works with three companies that offer innovative kits and instrumentation for the busy Haematology laboratory that needs fast, accurate results – Biomedomics (NC, USA), Alifax (Padova, Italy) and Viennalabs (Vienna, Austria).

SickleScan® Point of Care test

Sickle cell disease (SCD) is an inherited blood disorder which often causes red blood cells (RBCs) to become sickle-shaped through the presence of the abnormal haemoglobin S variant. Highly rigid sickle-shaped blood may have difficulty passing through small blood vessels, blocking the normal blood flow, damaging tissues, and ultimately leading to many of the complications of SCD. Additionally, RBCs containing mostly haemoglobin S live only about 16 days compared to 120 days for normal red blood cells. To initiate life-saving therapies, early diagnosis of SCD is key.

BioMedomics Sickle SCAN is a multiplexed, qualitative, point-of-care immunoassay to aid in the rapid diagnosis of sickle cell disorders

BioMedomics™ Sickle SCAN® is a multiplexed, qualitative, point-of-care immunoassay to aid in the rapid diagnosis of sickle cell disorders. The test is made up of three indicators which detect the presence of haemoglobins A, S, and C, allowing the user to rapidly distinguish between normal, carrier, and sickle cell disease samples. The test can be completed in 3 easy steps, giving real time results in under 5 minutes. It uses a small amount of whole blood from a fingerstick, heelstick, or venipuncture. A protocol for using blood spots is available on request.

The test is made up of three indicators which detect the presence of haemoglobins

The Sickle SCAN E95 Positive Control Kit is now available. This control material contains a combination of three human haemoglobin variants: HbA, HbS and HbC. It is intended to be used for validating the efficacy and quality of Sickle SCAN rapid test devices. Please contact us for further information.

ALIFAX® - ESR in 20 seconds

The erythrocyte sedimentation rate (ESR) is widely used as a screening or monitoring test for patients with acute or chronic inflammation. The reference technique for ESR is the Westergren method but this is time consuming and includes many variables that make quality control difficult such as sample collection, temperature and time of sample storage, equipment and methodology. .

Capillary photometry technology incorporated by Alifax in their ESR analysers measures red blood cell aggregation, providing automated ESR results in 20 seconds and overcoming the variables and limitations of the sedimentation method.

  • Erythrocyte Sedimentation Rate Measurements by TEST 1 Better Reflect Inflammation Than Do Those by the Westergren Method in Patients With Malignancy, Autoimmune Disease, or Infection
  • Choong-Hwan Cha, MD et al

Alifax Latex Control kits contain three samples with known low, medium and high values, and are available in 2 pack sizes (6 tests and 30 tests)

Alifax ESR analysers provide results in 20 seconds with high correlation with the Westergren method.

Test 1


Test 1 THL

Test 1 THL

Roller 20 PN


roller 20pn

Code SI R20-PN







Oxford Biosystems

184B Park Drive

Milton Park



OX14 4SE

Oxford Biosystems has pledged to be an Antibiotic Guardian

Members of:

BIVDA Member 2020 IBMS member